Cardiovascular morbidity and risk factors in renal transplant patients

Nephrology Dialysis Transplantation

Volumn 14, Issue 3, 1999, Pages 648-654

  Aakhus, Svend ^a,b   Dahl, Ketil ^a   Widerøe, Tor Erik ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cardiovascular disease; Cross sectional study; Cyclosporin A; Ischaemic heart disease; Renal transplant patients; Risk factors

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

AGE; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GENDER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032968407     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.3.648     Document Type: Article

References (27)

1. Brunner FP, Brynger H, Challah S et al. Renal replacement therapy in patients with diabetic nephropathy, 1980-1985, Nephrol Dial Transplant 1988; 3: 585-595
2. Fassbinder W, Brunner FP, Brynger H et al. Combined report of regular dialysis and transplantation in Europe XX, 1989. Nephrol Dial Transplant 1991; 6(Suppl 1): 5-35
3. Raine AEG, Margreiter R, Brunner FP et al. Report on management of renal failure in Europe, XXII, 1992. Nephrol Dial Transplant 1992; 7(Suppl. 2): 1-35
4. Lindholm A, Albrechtsen D, Frödin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995; 60; 451-457
5. Brunner FP, Fassbinder W, Broyer M et al. Combined report on regular dialysis and transplantation in Europe, XVIII, 1987. Springer, London, 1988; 5-32
6. Aakhus S, Dahl K, Widerøe TE. Hyperlipidaemia in renal transplant patients. J Int Med 1996; 239; 407-415
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
8. Holmen J, Midthjell K., Bjartveit K et al. The Nord-Trøndelag Health Survey 1984-86. Purpose, background and methods. Participation, non-participation and frequency distributions. Report no. 4. Senter for samfunnsmedisinsk forskning, Verdal, Norway, 1990. National Institute of Public Health, Community Medicine Research Centre. N-7651 Verdal, Norway
9. Altman DG. Practical statistics for medical research, first edition. Chapman & Hall, London, 1991; 268-270
10. Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223-233
11. Eagle KA, Rihal CS, Foster ED, Mickel MC, Gersh BJ. Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. J Am Coll Cardiol 1994; 23: 1091-1095
12. Vathsala A, Weinberg RB, Schoenberg L et al. Lipid abnormalities in cyclosporine-prednisone-treated renal transplant recipients. Transplantation 1989; 48: 37-43
13. Versluis DJ, Wenting GJ, Derkx FHM, Schalekamp MADH, Jeekel J, Weimar W. Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 1987; 44: 387-389
14. Reisman L, Lieberman KV, Burrows L, Schanzer H. Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone. Transplantation 1990; 49: 76-80
15. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165
16. Kasiske BL, Tortorice KL, Heim-Duthoy KL, Goryance JM, Rao KV. Lovastatin treatment of hypercholesterolemia in renal transplant recipients. Transplantation 1990; 49: 95-100
17. Goldberg R, Roth D. Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine. Transplantation 1996; 62: 1559-1564
18. Chapman JR, Marcen R, Arias M, Raine AEG, Dunnill MS, Morris PJ. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation 1987; 43: 860-864
19. Kahan BD, Flechner SM, Lorber MI, Golden D, Conley S, Van Buren CT. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987; 43: 197-204
20. Surdacki A, Wieczorek-Surdacka E, Sulowicz W, Dubiel JS. Effect of having a functioning cadaveric renal transplant on cardiovascular mortality risk in patients on renal replacement therapy. Nephrol Dial Transplant 1995; 10: 1218-1223
21. Cueto-Garcia L, Herrera J, Arriage J, Laredo C, Meaney E. Echocardiographic changes after successful renal transplantation in young nondiabetic patients. Chest 1983; 83: 56-61
22. Himelman RB, Landzberg JS, Simonson JS et al. Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 1988; 12: 915-923
23. Lipkin GW, Tucker B, Giles M, Raine AEG. Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens 1993; 11: 439-442
24. Woythaler JN, Singer SL, Kwan OIL et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. J Am Coll Cardiol 1983; 2: 305-311
25. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-1566
26. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988; 84: 985-992
27. Webb AT, Franks PJ, Reaveley DA, Greenhalgh RM, Brown EA. Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Eur J Vasc Surg 1993; 7: 523-527